Used in research settings to detect and quantify Nuclear Matrix Protein 22 (NMP-22) in biological samples, particularly urine. NMP-22 is a biomarker associated with bladder cancer, and this ELISA kit enables scientists to study its expression levels for potential diagnostic applications. It supports investigation into tumor cell proliferation and nuclear structural changes in cancerous tissues. The kit is not for diagnostic use but serves as a tool in oncology research, biomarker validation, and drug development studies focused on bladder cancer. Its high sensitivity allows detection of low-abundance NMP-22, facilitating studies on disease progression and therapeutic response in experimental models.